KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) EPS (Basic): 2009-2024

Historic EPS (Basic) for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $9.69.

  • Cme Group's EPS (Basic) fell 0.80% to $2.49 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.33, marking a year-over-year increase of 8.39%. This contributed to the annual value of $9.69 for FY2024, which is 9.24% up from last year.
  • Latest data reveals that Cme Group reported EPS (Basic) of $9.69 as of FY2024, which was up 9.24% from $8.87 recorded in FY2023.
  • Cme Group's 5-year EPS (Basic) high stood at $9.69 for FY2024, and its period low was $5.88 during FY2020.
  • Over the past 3 years, Cme Group's median EPS (Basic) value was $8.87 (recorded in 2023), while the average stood at $8.66.
  • As far as peak fluctuations go, Cme Group's EPS (Basic) dropped by 0.84% in 2020, and later grew by 24.15% in 2021.
  • Yearly analysis of 5 years shows Cme Group's EPS (Basic) stood at $5.88 in 2020, then grew by 24.15% to $7.30 in 2021, then grew by 1.51% to $7.41 in 2022, then grew by 19.70% to $8.87 in 2023, then increased by 9.24% to $9.69 in 2024.